IP Library › Granted Patent US 7,829,095
Granted Patent B2
US 7,829,095 · App. 10/359,704 · Granted Nov 9, 2010

Inhibitory monoclonal antibody against blood clotting factor VII-activating protease

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,829,095
App. No.
10/359,704
Granted
Nov 9, 2010
Kind
B2
Abstract

A monoclonal antibody which inhibits the blood clotting factor VII-activating protease and its proenzyme and a blood clotting factor VII-activating protease, stabilized by the addition of said monoclonal antibody, and its proenzyme are described. A suitable monoclonal antibody is produced by hybridoma cell line DSM ACC 2533. The application of the inhibitory, monoclonal antibody in the stabilization of blood clotting preparations and in preparations for reducing the coagulability of the blood is disclosed.

Claims (2)

1. A monoclonal antibody produced by hybridoma cell line DSM ACC 2533.

2. A hybridoma cell line deposited under accession number DSM ACC 2533.

Assignments (3)
CHANGE OF NAME Recorded Sep 10, 2007
From: ZLB BEHRING GMBH
To: CSL BEHRING GMBH
Reel/Frame 019840/0193 →
CHANGE OF NAME Recorded Nov 2, 2004
From: AVENTIS BEHRING GMBH
To: ZLB BEHRING GMBH
Reel/Frame 015326/0521 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2003
From: ROEMISCH, JUERGEN; LANG, WIEGAND; FEUSSNER, ANNETTE; MUTH-NAUMANN, GUDRUN; STOEHR, HANS-ARNOLD; KANNEMAIER, CHRISTIAN; PREISSNER, KLAUS; NAKAZAWA, FUMIE
To: AVENTIS BEHRING GMBH
Reel/Frame 014305/0507 →